Work

A Phase 3 Study Evaluating The Efficacy And Safety Of Benralizumab In Patients With Hypereosinophilic Syndrome

Year: 2023

Type: article

Source: Journal of Allergy and Clinical Immunology

DOI: 10.1016/j.jaci.2022.12.352

Authors: Princess Ogbogu, Amy Klion, Florence Roufosse, Praveen Akuthota, Paneez Khoury, Vivian Shih, Diane Griffis, Himanshu Parikh, Ron Chen, Ying Fan, Gaëll Mayer, Rohit Katial, Ioannis Psallidas

Institutions: Rainbow Babies & Children's Hospital, Case Western Reserve University, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Erasmus Hospital, University of California San Diego, AstraZeneca (United Kingdom)

Language: English

Topic: Eosinophilic Disorders and Syndromes

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4319082769

FWCI: 0.173

Cites:

Cited by: 1

Related to: 10